Bryan joined Adarza in January of 2017 as President to provide leadership during the company’s transition from a technology developer to a commercial technology provider. He brings over 20 years of experience and a successful track record of developing and commercializing new technologies. He most recently served as Scientific Leader within the Genomics Division at Becton Dickinson (BD). Prior to that he was CSO at GenCell Biosystems, which was acquired by BD in 2014. Previously he held various R&D leadership roles at Monsanto and Pfizer. Bryan has a BS in Biochemistry from Truman State University.
Bryan WitherbeeTrudy Sandor